An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients

scientific article

An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2174/1874205X01105010068
P932PMC publication ID3204415
P698PubMed publication ID22046204
P5875ResearchGate publication ID51761003

P2093author name stringAndrea Brancaccio
Ernesto Pavoni
Bruno Giardina
Francesca Sciandra
Manuela Bozzi
Enzo Ricci
Giorgio Tasca
Roberta Tittarelli
P2860cites workDeficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathiesQ24651944
Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophyQ28268625
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixQ28296676
Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null miceQ28590908
The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathiesQ30499359
Dysferlin and the plasma membrane repair in muscular dystrophyQ33201061
Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycanQ33234933
Making sense of the limb-girdle muscular dystrophiesQ33701932
An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.Q34091913
POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changes.Q34699567
A dystroglycan mutation associated with limb-girdle muscular dystrophy.Q34767085
Dystroglycan: important player in skeletal muscle and beyondQ36051591
Progressive muscular dystrophy in alpha-sarcoglycan-deficient miceQ36276730
Alpha-dystroglycan, the usual suspect?Q36313690
The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesisQ36592193
Functional diversity of dystroglycanQ37419780
Dystroglycanopathies: coming into focusQ37852376
Expanding the clinical spectrum of POMT1 phenotype.Q41919581
Dystroglycan distribution in adult mouse brain: a light and electron microscopy studyQ42504975
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophiesQ42524150
The structure of the N-terminal region of murine skeletal muscle alpha-dystroglycan discloses a modular architecture.Q45028092
Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant.Q51894973
Congenital muscular dystrophy with defective alpha-dystroglycan, cerebellar hypoplasia, and epilepsyQ55880074
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1CQ77346768
P921main subjectcongenital disorderQ727096
lessons learnedQ1673259
P304page(s)68-74
P577publication date2011-10-20
P1433published inThe open neurology journalQ27722068
P1476titleAn immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients
P478volume5

Search more.